Upinder Kaur

2.0k total citations
92 papers, 1.2k citations indexed

About

Upinder Kaur is a scholar working on Infectious Diseases, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Upinder Kaur has authored 92 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 15 papers in Surgery and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Upinder Kaur's work include SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 Clinical Research Studies (11 papers) and Liver Disease and Transplantation (8 papers). Upinder Kaur is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 Clinical Research Studies (11 papers) and Liver Disease and Transplantation (8 papers). Upinder Kaur collaborates with scholars based in India, United States and Italy. Upinder Kaur's co-authors include Sankha Shubhra Chakrabarti, Sasanka Chakrabarti, J B Dilawari, Yogesh Chawla, Ganguly Nk, Akashdeep Singh Chauhan, Upasana Ganguly, Shahid Jameel, P Bambery and Luciano Saso and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Gut.

In The Last Decade

Upinder Kaur

84 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Upinder Kaur India	20	313	290	186	184	174	92	1.2k
Concetta Scazzone Italy	28	177 0.6×	175 0.6×	199 1.1×	661 3.6×	243 1.4×	82	2.1k
Iain MacPhee United Kingdom	24	212 0.7×	86 0.3×	65 0.3×	123 0.7×	197 1.1×	71	2.4k
Erkan Cüre Türkiye	22	242 0.8×	41 0.1×	82 0.4×	175 1.0×	246 1.4×	102	1.4k
Harmanjit Singh India	16	141 0.5×	73 0.3×	66 0.4×	173 0.9×	218 1.3×	97	1.1k
Helena Hiemisch Lobo Borba Brazil	17	162 0.5×	87 0.3×	49 0.3×	346 1.9×	134 0.8×	47	1.0k
Ruihua Yin China	20	246 0.8×	34 0.1×	176 0.9×	435 2.4×	316 1.8×	38	1.5k
Kuan‐Fu Liao Taiwan	26	284 0.9×	66 0.2×	91 0.5×	514 2.8×	432 2.5×	138	2.2k
Bonnie Hepburn United States	11	153 0.5×	53 0.2×	118 0.6×	219 1.2×	136 0.8×	19	1.7k
Zhixiong Wu China	17	253 0.8×	88 0.3×	63 0.3×	112 0.6×	212 1.2×	39	907
Sunita Rehal United Kingdom	10	185 0.6×	66 0.2×	164 0.9×	181 1.0×	71 0.4×	14	807

Countries citing papers authored by Upinder Kaur

Since Specialization

Citations

This map shows the geographic impact of Upinder Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Upinder Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Upinder Kaur more than expected).

Fields of papers citing papers by Upinder Kaur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Upinder Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Upinder Kaur. The network helps show where Upinder Kaur may publish in the future.

Co-authorship network of co-authors of Upinder Kaur

This figure shows the co-authorship network connecting the top 25 collaborators of Upinder Kaur. A scholar is included among the top collaborators of Upinder Kaur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Upinder Kaur. Upinder Kaur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kaur, Upinder, et al.. (2023). Lecanemab: More Questions Than Answers!. Clinical Drug Investigation. 44(1). 1–10. 18 indexed citations

Kaur, Upinder, et al.. (2022). A Prospective Observational Study on BBV152 Coronavirus Vaccine Use in Adolescents and Comparison with Adults: Interim Results of the First Real-World Safety Analysis. Drug Safety. 45(10). 1099–1109. 4 indexed citations

Kaur, Upinder, Sankha Shubhra Chakrabarti, & Tejas Patel. (2021). Renin–angiotensin–aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis. Therapeutic Advances in Drug Safety. 12. 1561463569–1561463569. 9 indexed citations

Kaur, Upinder, et al.. (2020). Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2. European Journal of Pharmacology. 887. 173545–173545. 30 indexed citations

Chakrabarti, Sankha Shubhra, Upinder Kaur, Anup Singh, et al.. (2020). Of Cross-Immunity, Herd Immunity and Country-Specific Plans: Experiences from COVID-19 in India. SSRN Electronic Journal. 1 indexed citations

Kaur, Upinder, et al.. (2020). Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion. Current Drug Targets. 22(2). 192–201. 29 indexed citations

Chakrabarti, Sankha Shubhra, Upinder Kaur, Anup Singh, et al.. (2020). Of Cross-immunity, Herd Immunity and Country-specific Plans: Experiences from COVID-19 in India. Aging and Disease. 11(6). 1339–1339. 13 indexed citations

Chakrabarti, Sankha Shubhra, et al.. (2019). APOE4 allele in north Indian elderly patients with dementia or late onset depression-a multiple-disease case control study.. PubMed Central. 8(3). 135–140. 1 indexed citations

Kaur, Upinder, et al.. (2019). Esketamine: a glimmer of hope in treatment-resistant depression. European Archives of Psychiatry and Clinical Neuroscience. 271(3). 417–429. 55 indexed citations

10.

Ganguly, Upasana, Sankha Shubhra Chakrabarti, Upinder Kaur, Anwesha Mukherjee, & Sasanka Chakrabarti. (2018). Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy. Current Neuropharmacology. 16(7). 1086–1097. 37 indexed citations

11.

Kaur, Upinder, et al.. (2018). Spinal anesthesia as contributing factor to chronic low backache: A myth or reality. 5(3). 40–45. 1 indexed citations

12.

Singh, Virendra, et al.. (2000). Budd–Chiari syndrome: Our experience of 71 patients. Journal of Gastroenterology and Hepatology. 15(5). 550–554. 63 indexed citations

13.

Chawla, Yogesh, J B Dilawari, Radha K. Dhiman, et al.. (1997). Sclerotherapy in Noncirrhotic Portal Fibrosis. Digestive Diseases and Sciences. 42(7). 1449–1453. 21 indexed citations

14.

Agnihotri, Navneet, et al.. (1996). PORTAL HAEMODYNAMICS AND HEPATIC BLOOD FLOW. Journal of Gastroenterology and Hepatology. 11(10). 971–977. 8 indexed citations

15.

Dilawari, J B, et al.. (1993). Hepatic‐pericardio‐phrenic collateral (natural shunt) in a patient with Budd‐Chiari syndrome. Journal of Gastroenterology and Hepatology. 8(2). 202–205. 2 indexed citations

16.

Bambery, P, Sonal Jindal, Upinder Kaur, & O. P. Sharma. (1991). Pulmonary complications of malaria.. 51. 101–133. 2 indexed citations

17.

Chawla, Yogesh, et al.. (1990). Sclerotherapy in extrahepatic portal venous obstruction.. Gut. 31(2). 213–216. 31 indexed citations

18.

Chawla, Yogesh, et al.. (1990). Percutaneous liver biopsy: A safe outpatient procedure. Journal of Gastroenterology and Hepatology. 5(1). 94–95. 6 indexed citations

19.

Bambery, P, V. Sakhuja, Amod Gupta, et al.. (1987). Wegener's granulomatosis in North India. Rheumatology International. 7(6). 243–247. 9 indexed citations

20.

Bambery, P, S. Malhotra, Upinder Kaur, Rakesh Kumar Chadda, & S. D. Deodhar. (1987). Anorexia nervosa in a patient with systemic lupus erythematosus. Rheumatology International. 7(4). 177–179. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact